Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab plus FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children's Oncology Group Report

被引：0
|
作者：
Cairo, Mitchell S. [1 ]
Lynch, James [2 ]
Harrison, Lauren [1 ]
van de Ven, Carmella [3 ]
Gross, Thomas [4 ]
Shiramizu, Bruce [5 ]
Sanger, Warren [6 ]
Perkins, Sherrie L. [7 ]
Goldman, Stanton [8 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY 43210 USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Childrens Oncol Grp, Omaha, NE 96822 USA
[3] Columbia Univ, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH USA
[5] Univ Hawaii, Honolulu, HI USA
[6] Univ Nebraska Med Ctr, Dept Human Genet, Omaha, NE USA
[7] ARUP Labs, Hematopathol Off, Salt Lake City, UT USA
[8] Med City Childrens, Dallas, TX USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [21] A Study of Rituximab and Ifosfamide, Carboplatin, and Etoposide Chemotherapy in Children with Recurrent/Refractory B-Cell (CD20+) Non-Hodgkin Lymphoma and Mature B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Griffin, Timothy C.
    Weitzman, Sheila
    Weinstein, Howard
    Chang, Myron
    Cairo, Mitchell
    Hutchison, Robert
    Shiramizu, Bruce
    Wiley, Joseph
    Woods, Deborah
    Barnich, Margaret
    Gross, Thomas G.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 177 - 181
  • [22] INOTUZUMAB OZOGAMICIN IN B-CELL NON-HODGKIN'S LYMPHOMA REFRACTORY TO RITUXIMAB plus CHEMOTHERAPY OR RADIOIMMUNOTHERAPY
    Ogura, M.
    Leach, J.
    Egyed, M.
    Ando, K.
    Hatake, K.
    Tobinai, K.
    Feldman, T.
    Hua, S.
    Volkert, A.
    Vandendries, E.
    Goy, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [23] Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis
    Hua, Qingling
    Zhu, Yanzhe
    Liu, Hu
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (06) : 365 - 370
  • [24] The treatment of mature B-NHL with the involvement of CNS in children and adolescents with chemotherapy and rituximab; experience of multicentral study
    Smirnova, N.
    Samochatova, E.
    Feodorova, A.
    Belogurova, M.
    Doubrovina, M.
    Khlebnikova, O.
    Litvinov, D.
    Ponomareva, N.
    Nikonova, O.
    Shamardina, A.
    Maschan, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 58 - 59
  • [25] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] TANDEM AUTOLOGOUS ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED/REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Gardenswartz, A.
    Mehta, B.
    El-Mallawany, N.
    van de Ven, C.
    Hochberg, J.
    Flower, A.
    Morris, E.
    Harrison, L.
    Basso, J.
    Gerard, P.
    Ayello, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [27] Phase II study of oral Fludarabine (FAMP) in combination with rituximab in indolent B-cell non-hodgkin lymphoma (B-NHL)
    Ishizawa, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Itoh, Kuniaki
    Aorishima, Yasuo
    Ando, Kiyoshi
    Yamamoto, Joji
    Watanabe, Takashi
    Uchida, Toshiki
    Nakata, Masanobu
    Hayashi, Masaki
    Hotta, Tomomitsu
    BLOOD, 2007, 110 (11) : 387A - 387A
  • [28] Use of immunoglobulin heavy chain primer pools to assess minimal residual disease/persistent disease (MRD/PD) in children and adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL): A Children's Oncology Group report.
    Shiramizu, B.
    Goldman, S.
    Kusao, I.
    Agsalda, M.
    Lynch, J. C.
    Harrison, L.
    Gross, T. G.
    Sanger, W.
    Perkins, S. L.
    Cairo, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] B cell non-Hodgkin's lymphoma: rituximab safety experience
    Mohrbacher, A
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 3) : S19 - S25
  • [30] B cell non-Hodgkin's lymphoma: rituximab safety experience
    Ann Mohrbacher
    Arthritis Research & Therapy, 7
12345